Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial

J Behav Med. 2013 Dec;36(6):556-66. doi: 10.1007/s10865-012-9451-z. Epub 2012 Sep 29.

Abstract

Effects of a cognitive behavioural treatment (CBT) in type 2 diabetes patients were studied in a randomised controlled trial. Patients were recruited from a diabetes care system (DCS). The intervention group (n = 76) received managed care from the DCS and CBT. The control group (n = 78) received managed care only. Effects on risk of developing coronary heart disease (CHD), clinical characteristics, lifestyle, determinants of behaviour change, quality of life, and depression were assessed after 6 and 12 months. The intervention did not result in a significant reduction of CHD risk (difference between intervention and control group was -0.32 % (95 % CI: -2.27; 1.63). The amount of heavy physical activity increased significantly in the intervention group at 6 months [intervention versus control group was 20.14 min/day (95 % CI: 4.6; 35.70)]. Quality of life and level of depression improved as well. All effects disappeared after 6 months. No effects were found on clinical characteristics.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cognitive Behavioral Therapy*
  • Coronary Disease / etiology*
  • Depression
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / psychology
  • Diabetes Mellitus, Type 2 / therapy*
  • Female
  • Humans
  • Life Style
  • Male
  • Managed Care Programs*
  • Middle Aged
  • Quality of Life / psychology*
  • Risk
  • Surveys and Questionnaires
  • Treatment Outcome